Capricor Therapeutics (NASDAQ:CAPR) Price Target Raised to $30.00 at Cantor Fitzgerald
Capricor Therapeutics (NASDAQ:CAPR – Free Report) had its price target raised by Cantor Fitzgerald from $25.00 to $30.00 in a research report released on Thursday morning,Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. Other equities research analysts have also recently issued reports about the stock. HC Wainwright reiterated a “buy” […]
More Stories
**DarioHealth Corp. Enters Into Securities Purchase Agreements for Private Placement Financing****
** On December 16, 2024, DarioHealth Corp. (NASDAQ: DRIO) finalized securities purchase agreements with accredited investors, marking an important step...
Tamarack Valley Energy (OTCMKTS:TNEYF) Shares Down 1.7% – Should You Sell?
Tamarack Valley Energy Ltd. (OTCMKTS:TNEYF – Get Free Report) shares dropped 1.7% during mid-day trading on Monday . The company...
White Gold (CVE:WGO) Stock Price Down 4.7% – What’s Next?
Shares of White Gold Corp. (CVE:WGO – Get Free Report) fell 4.7% during trading on Monday . The company traded...
Anglo Pacific Group (TSE:APY) Stock Price Down 4.2% – Here’s Why
Anglo Pacific Group plc (TSE:APY – Get Free Report)’s stock price dropped 4.2% on Monday . The company traded as...
CanniMed Therapeutics (TSE:CMED) Trading Down 5.3% – Here’s Why
CanniMed Therapeutics Inc. (TSE:CMED – Get Free Report)’s stock price fell 5.3% on Monday . The stock traded as low...
Van Elle (LON:VANL) Trading Down 2.6% – Here’s Why
Van Elle Holdings plc (LON:VANL – Get Free Report)’s stock price was down 2.6% on Monday . The company traded...